Human Urinary Kallidinogenase decreases recurrence risk and promotes good recovery

OBJECTIVES: To evaluate the efficacy of Human Urinary Kallidinogenase (HUK) for secondary stroke prevention in the treatment of acute ischemic stroke (AIS) patients. MATERIALS AND METHODS: In this retrospective study, from October 2016 to June 2017, 300 consecutive AIS patients were registered in ou...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Dong, Chen, Xin, Li, Dongmei, Liu, Shuang, Lyu, Yi, Feng, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085914/
https://www.ncbi.nlm.nih.gov/pubmed/30030910
http://dx.doi.org/10.1002/brb3.1033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085914/
https://www.ncbi.nlm.nih.gov/pubmed/30030910
http://dx.doi.org/10.1002/brb3.1033

Ejemplares similares